Parallel profiling of DNA methylation and hydroxymethylation highlights neuropathology-associated epigenetic variation in Alzheimer’s disease
暂无分享,去创建一个
Safa Al-Sarraj | Claire Troakes | Eilis Hannon | J. Mill | K. Lunnon | C. Troakes | S. Al-Sarraj | E. Hannon | E. Pishva | J. Burrage | Rebecca G. Smith | Adam R Smith | Jonathan Mill | Katie Lunnon | D. V. D. van den Hove | Rebecca G Smith | Ehsan Pishva | Janou A Y Roubroeks | Joe Burrage | Carolyn Sloan | Daniel L van den Hove | Adam R. Smith | C. Sloan | Joe Burrage | J. Roubroeks
[1] D. Bennett,et al. Cross-tissue methylomic profiling strongly implicates a role for cortex-specific deregulation of ANK1 in Alzheimer’s disease neuropathology , 2014, Nature neuroscience.
[2] D. Voronin,et al. Functional role of proteins containing ankyrin repeats , 2008, Cell and Tissue Biology.
[3] Meng Zhou,et al. MLML: consistent simultaneous estimates of DNA methylation and hydroxymethylation , 2013, Bioinform..
[4] D. Bennett,et al. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease , 2014, Nature Neuroscience.
[5] Winnie S. Liang,et al. ANK1 is up-regulated in laser captured microglia in Alzheimer’s brain; the importance of addressing cellular heterogeneity , 2017, PloS one.
[6] Clifford A. Meyer,et al. PKA-dependent regulation of the histone lysine demethylase complex PHF2–ARID5B , 2011, Nature Cell Biology.
[7] J. Mill,et al. A cross-brain regions study of ANK1 DNA methylation in different neurodegenerative diseases , 2019, Neurobiology of Aging.
[8] D. Bennett,et al. A genome-wide profiling of brain DNA hydroxymethylation in Alzheimer's disease , 2017, Alzheimer's & Dementia.
[9] R. Weksberg,et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray , 2013, Epigenetics.
[10] J. Mill,et al. Epigenetic studies in Alzheimer's disease: Current findings, caveats, and considerations for future studies , 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[11] H. Leonhardt,et al. DNA methylation analysis on purified neurons and glia dissects age and Alzheimer’s disease-specific changes in the human cortex , 2018, Epigenetics & Chromatin.
[12] Nick C Fox,et al. Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease , 2011, Nature Genetics.
[13] Nick C Fox,et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.
[14] Brent S. Pedersen,et al. Comb-p: software for combining, analyzing, grouping and correcting spatially correlated P-values , 2012, Bioinform..
[15] Jean YH Yang,et al. Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.
[16] R. Yan,et al. β-Site Amyloid Precursor Protein Cleaving Enzyme 1(BACE1) Regulates Notch Signaling by Controlling the Cleavage of Jagged 1 (Jag1) and Jagged 2 (Jag2) Proteins , 2014, The Journal of Biological Chemistry.
[17] Gangning Liang,et al. Gene body methylation can alter gene expression and is a therapeutic target in cancer. , 2014, Cancer cell.
[18] Eric-Wubbo Lameijer,et al. Identification and systematic annotation of tissue-specific differentially methylated regions using the Illumina 450k array , 2013, Epigenetics & Chromatin.
[19] E. Aronica,et al. Induction of Dickkopf-1, a Negative Modulator of the Wnt Pathway, Is Associated with Neuronal Degeneration in Alzheimer's Brain , 2004, The Journal of Neuroscience.
[20] M. Tellez-Plaza,et al. MLML2R: an R package for maximum likelihood estimation of DNA methylation and hydroxymethylation proportions , 2019, Statistical applications in genetics and molecular biology.
[21] D. Bennett,et al. Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer’s disease neuropathology , 2018, Alzheimer's & Dementia.
[22] B. Hyman,et al. Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.
[23] K. Lunnon,et al. Using induced pluripotent stem cells to explore genetic and epigenetic variation associated with Alzheimer's disease. , 2017, Epigenomics.
[24] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[25] C. Jack,et al. PREDICTORS OF REGIONAL TAU-PET UPTAKE: MAYO CLINIC STUDY OF AGING , 2016, Alzheimer's & Dementia.
[26] D. G. Clark,et al. Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.
[27] Manolis Kellis,et al. Alzheimery's disease pathology is associated with early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci , 2014, Nature Neuroscience.
[28] Timothy E. Reddy,et al. Dynamic DNA methylation across diverse human cell lines and tissues , 2013, Genome research.
[29] J. Mill,et al. Variation in 5-hydroxymethylcytosine across human cortex and cerebellum , 2016, Genome Biology.
[30] V. Pankratz,et al. Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study , 2011, Molecular Neurodegeneration.
[31] Eilis Hannon,et al. 5-hydroxymethylcytosine is highly dynamic across human fetal brain development , 2017, BMC Genomics.
[32] Martin J. Aryee,et al. A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression , 2013, Epigenetics.
[33] J. Mill,et al. Increased DNA methylation near TREM2 is consistently seen in the superior temporal gyrus in Alzheimer's disease brain , 2016, Neurobiology of Aging.
[34] N. Inestrosa,et al. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1ΔE9 mouse model of Alzheimer's disease , 2010, Molecular Psychiatry.
[35] Frank Dudbridge,et al. Estimation of a significance threshold for epigenome‐wide association studies , 2017, Genetic epidemiology.
[36] M. Biel,et al. Quantification of the sixth DNA base hydroxymethylcytosine in the brain. , 2010, Angewandte Chemie.
[37] D. Standaert,et al. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration , 2016, The Journal of Neuroscience.
[38] J. Mill,et al. Variation in 5-hydroxymethylcytosine across human cortex and cerebellum , 2016, Genome Biology.
[39] Ruth Pidsley,et al. A data-driven approach to preprocessing Illumina 450K methylation array data , 2013, BMC Genomics.
[40] N. Heintz,et al. The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain , 2009, Science.
[41] E. Hol,et al. Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction , 2014, Neurobiology of Aging.
[42] Bente Pakkenberg,et al. Aberrant Wnt signaling pathway in medial temporal lobe structures of Alzheimer’s disease , 2015, Journal of Neural Transmission.
[43] Esiri Mm. Brain banks: the Oxford experience. , 1993, Journal of neural transmission. Supplementum.
[44] M. Lovell,et al. Single-Base Resolution Mapping of 5-Hydroxymethylcytosine Modifications in Hippocampus of Alzheimer’s Disease Subjects , 2017, Journal of Molecular Neuroscience.
[45] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .